Mineral medicine: from traditional drugs to multifunctional delivery systems
Open Access
- 10 February 2022
- journal article
- review article
- Published by Springer Science and Business Media LLC in Chinese Medicine
- Vol. 17 (1), 1-30
- https://doi.org/10.1186/s13020-022-00577-9
Abstract
Mineral drugs are an important constituent of traditional Chinese medicine (TCM). Taking minerals that contain heavy metals as drugs is a very national characteristic part of TCM. However, the safety and scientific nature of mineral drugs are controversial owing to their heavy metals and strong toxicity. In 2000, the Food and Drug Administration (FDA) authorized arsenic trioxide (ATO) as first-line therapy for acute promyelocytic leukemia. This makes the development and utilization of mineral drugs become a research hotspot. The development of nanomedicine has found a great prospect of mineral drugs in nano-delivery carriers. And that will hold promise to address the numerous biological barriers facing mineral drug formulations. However, the studies on mineral drugs in the delivery system are few at present. There is also a lack of a detailed description of mineral drug delivery systems. In this review, the advanced strategies of mineral drug delivery systems in tumor therapy are summarized. In addition, the therapeutic advantages and research progress of novel mineral drug delivery systems are also discussed. Here, we hope that this will provide a useful reference for the design and application of new mineral drug delivery systems.Funding Information
- National Natural Science Foundation of China (81903557, 82074024)
This publication has 144 references indexed in Scilit:
- Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticlesBiomaterials, 2013
- Effects of Bai-Hu decoction on fever induced by lipopolysaccharideThe Kaohsiung Journal of Medical Sciences, 2013
- Theranostic Nanoparticles with Controlled Release of Gemcitabine for Targeted Therapy and MRI of Pancreatic CancerACS Nano, 2013
- Mesoporous silica nanoparticles as antigen carriers and adjuvants for vaccine deliveryNanoscale, 2013
- Halloysite Clay Nanotubes for Resveratrol Delivery to Cancer CellsMacromolecular Bioscience, 2012
- Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriersInternational Journal of Nanomedicine, 2012
- A multifunctional mesoporous nanocontainer with an iron oxide core and a cyclodextrin gatekeeper for an efficient theranostic platformJournal of Materials Chemistry, 2012
- Magnetoliposomes as magnetic resonance imaging contrast agentsWIREs Nanomedicine and Nanobiotechnology, 2011
- Silica nanoparticle coated liposomes: A new type of hybrid nanocapsule for proteinsInternational Journal of Pharmaceutics, 2010
- Comparative study of the effects of Gypsum Fibrosum and Gypsum Fibrosum Preparatum in promoting granulationJournal of Chinese Integrative Medicine, 2006